The US Food and Drug Administration action’s, or lack thereof, on the opioid epidemic once again could influence a commissioner confirmation fight.
A group of 30 organizations, including several involved in fighting the opioid pandemic, outlined their “strong opposition” to acting FDA Commissioner Janet Woodcock becoming President Biden’s nominee for the permanent position in a 27 January
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?